This study is currently not recruiting participants.

SynapDx Autism Spectrum Disorder Gene Expression Analysis (STORY) Study

Study on Blood Test for Diagnosing Developmental Disorders

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to develop a blood test validating a Ribonucleic Acid (RNA)-based signature that can distinguish between ASD and other developmental disorders in order to facilitate a more rapid and accurate diagnosis.

Detailed description of study

The purpose of this study is to develop a blood test validating a Ribonucleic Acid (RNA)-based signature that can distinguish between ASD and other developmental disorders in order to facilitate a more rapid and accurate diagnosis.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Autism Spectrum Disorder
  • Age: 100 years or below
  • Gender: All

This study investigates a blood test that uses a Ribonucleic Acid (RNA)-based signature to differentiate between Autism Spectrum Disorder (ASD) and other developmental disorders. RNA is a molecule similar to DNA that plays a crucial role in coding, decoding, regulation, and expression of genes.

Participants will undergo blood tests to validate the RNA-based signature. This involves collecting blood samples to analyze the RNA patterns that might indicate the presence of ASD or other developmental disorders.

  • Who can participate: Participants aged 18-65 with a diagnosis of Autism Spectrum Disorder (ASD) or other developmental disorders may be eligible.
  • Study details: Participants will provide blood samples for testing. The study aims to identify RNA patterns that differentiate between ASD and other disorders.
Updated on 19 Feb 2024. Study ID: 1304011066

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team